Cas no 364779-14-6 (Ginsenoside Rk2)
Ginsenoside Rk2 Chemical and Physical Properties
Names and Identifiers
-
- Ginsenoside RK2
- (3β,12β)-<wbr>
- LogP
- β-D-gluco<wbr>
- 3beta,12beta-Dihydroxydammar-20(21),24-diene-3-O-beta-D-glucopyranoside
- PAN 20
- 8137AH
- 364779-14-6
- GinsenosideRk2
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
- CHEMBL3594354
- MFCD11656143
- AKOS030528624
- HY-N2504
- FS-8006
- CS-0022775
- AC-34665
- (+)-Ginsenoside Rk2
- DA-73733
- (2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5AR,7S,9AR,9BR,11R,11AR)-11-HYDROXY-3A,3B,6,6,9A-PENTAMETHYL-1-(6-METHYLHEPTA-1,5-DIEN-2-YL)-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-7-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
- (3?,12?)-12-Hydroxydammara-20,24-dien-3-yl ?-D-glucopyranoside; 3?,12?-Dihydroxydammar-20(21),24-diene-3-O-?-D-glucopyranoside; PAN 20;
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-3-yl)oxy)oxane-3,4,5-triol
- Ginsenoside Rk2
-
- Inchi: 1S/C36H60O7/c1-20(2)10-9-11-21(3)22-12-16-36(8)28(22)23(38)18-26-34(6)15-14-27(33(4,5)25(34)13-17-35(26,36)7)43-32-31(41)30(40)29(39)24(19-37)42-32/h10,22-32,37-41H,3,9,11-19H2,1-2,4-8H3/t22-,23-,24-,25+,26-,27+,28+,29-,30+,31-,32+,34+,35-,36-/m1/s1
- InChI Key: WMGBQZAELMGYNO-YMWSGFAJSA-N
- SMILES: O[C@@H]1C[C@@H]2[C@@]3(C)CC[C@@H](C(C)(C)[C@@H]3CC[C@@]2(C)[C@]2(C)CC[C@H](C(=C)CC/C=C(\C)/C)[C@H]21)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O
Computed Properties
- Exact Mass: 604.4341
- Monoisotopic Mass: 604.434
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 43
- Rotatable Bond Count: 7
- Complexity: 1070
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 14
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 120
- Molecular Weight: 604.9
- XLogP3: 7
Experimental Properties
- Color/Form: Powder
- Density: 1.17±0.1 g/cm3 (20 oC 760 Torr),
- Melting Point: Not available
- Boiling Point: 693.895°C at 760 mmHg
- Flash Point: 373.454°C
- Refractive Index: 1.567
- Solubility: Insuluble (4.2E-4 g/L) (25 oC),
- PSA: 119.61
- Vapor Pressure: 0.0±4.9 mmHg at 25°C
Ginsenoside Rk2 Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement:
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Safety Instruction: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
Ginsenoside Rk2 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | G410230-1mg |
Ginsenoside RK2 |
364779-14-6 | 1mg |
$ 402.00 | 2023-09-07 | ||
| TRC | G410230-2.5mg |
Ginsenoside RK2 |
364779-14-6 | 2.5mg |
$ 890.00 | 2023-09-07 | ||
| Chengdu Biopurify Phytochemicals Ltd | BP1473-10mg |
Ginsenoside RK2 |
364779-14-6 | 98% | 10mg |
$380 | 2021-09-23 | |
| Chengdu Biopurify Phytochemicals Ltd | BP1473-5mg |
Ginsenoside RK2 |
364779-14-6 | 98% | 5mg |
$196 | 2021-09-23 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | G99240-10mg |
Ginsenoside Rk2 |
364779-14-6 | ,HPLC≥98% | 10mg |
¥3358.0 | 2023-09-07 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce56524-1mg |
Ginsenoside Rk2 |
364779-14-6 | 98% | 1mg |
¥0.00 | 2023-09-07 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce56524-5mg |
Ginsenoside Rk2 |
364779-14-6 | 98% | 5mg |
¥0.00 | 2023-09-07 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN1095-1 mg |
Ginsenoside Rk2 |
364779-14-6 | 1mg |
¥2490.00 | 2022-04-26 | ||
| ChemFaces | CFN92818-5mg |
Ginsenoside Rk2 |
364779-14-6 | >=98% | 5mg |
$318 | 2021-07-22 | |
| MedChemExpress | HY-N2504-1mg |
Ginsenoside Rk2 |
364779-14-6 | 99.25% | 1mg |
¥1600 | 2025-04-16 |
Ginsenoside Rk2 Suppliers
Ginsenoside Rk2 Related Literature
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
-
Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
Additional information on Ginsenoside Rk2
Comprehensive Overview of Ginsenoside Rk2 (CAS No. 364779-14-6): Properties, Benefits, and Applications
Ginsenoside Rk2 (CAS No. 364779-14-6) is a rare and highly bioactive saponin compound derived from Panax ginseng, a traditional herb renowned for its adaptogenic and therapeutic properties. As a member of the ginsenoside family, Rk2 has garnered significant attention in recent years due to its unique chemical structure and potential health benefits. This article delves into the molecular characteristics, pharmacological effects, and emerging applications of Ginsenoside Rk2, addressing common queries such as "What is Ginsenoside Rk2 used for?" and "How does Ginsenoside Rk2 differ from other ginsenosides?"
The chemical structure of Ginsenoside Rk2 features a dammarane-type triterpenoid skeleton, distinguishing it from more common ginsenosides like Rb1 or Rg1. Its molecular formula is C36H60O8, with a molar mass of 620.86 g/mol. Unlike protopanaxadiol (PPD) or protopanaxatriol (PPT)-type ginsenosides, Rk2 is classified as a steam-processed ginsenoside, formed through thermal degradation during the preparation of red ginseng. This process enhances its bioavailability and bioactivity, making it a subject of intense research in nutraceutical and pharmaceutical fields.
Recent studies highlight Ginsenoside Rk2's potential in addressing modern health concerns, particularly in the realms of anti-aging, neuroprotection, and metabolic regulation. For instance, its ability to modulate AMP-activated protein kinase (AMPK) pathways has sparked interest in its application for weight management and diabetes prevention—topics frequently searched in conjunction with "natural remedies for metabolic syndrome." Additionally, its anti-inflammatory properties align with growing consumer demand for plant-based alternatives to conventional drugs.
In the cosmeceutical industry, Ginsenoside Rk2 is gaining traction as a key ingredient in anti-wrinkle and skin-rejuvenating formulations. Its mechanism of action involves collagen synthesis stimulation and matrix metalloproteinase (MMP) inhibition, addressing the popular search query "How to boost collagen naturally?" Furthermore, its antioxidant capacity exceeds that of vitamin C, making it a compelling option for oxidative stress management—a hot topic in preventive healthcare discussions.
From a commercial perspective, the global market for specialized ginsenosides like Rk2 is projected to grow at a CAGR of 8.3% from 2023 to 2030, driven by increasing demand for evidence-based herbal supplements. However, challenges remain in standardization and large-scale production due to its low natural abundance. Innovative extraction techniques, such as enzymatic biotransformation and supercritical fluid extraction, are being explored to overcome these limitations—an aspect often queried as "How is Ginsenoside Rk2 extracted?"
Quality control of Ginsenoside Rk2 products requires advanced analytical methods like HPLC-UV or LC-MS to verify purity and potency. Regulatory frameworks, including USP and EP monographs, are gradually incorporating standards for rare ginsenosides, reflecting their growing therapeutic importance. Consumers searching for "How to identify pure Ginsenoside Rk2?" should look for third-party certifications and COA (Certificate of Analysis) documentation.
Future research directions for Ginsenoside Rk2 include exploring its synergistic effects with other bioactive compounds and developing targeted delivery systems to enhance its absorption. As interest in precision nutrition and personalized medicine grows, this compound may play a pivotal role in tailored wellness solutions. Its multifaceted benefits—spanning from cognitive support to cardiovascular protection—position it as a versatile candidate for next-generation functional foods and therapeutic formulations.
364779-14-6 (Ginsenoside Rk2) Related Products
- 142735-55-5(b-D-Galactopyranoside, (1b,3b,16b,22S)-1-(b-D-glucopyranosyloxy)-3,22-dihydroxycholest-5-en-16-yl(9CI))
- 147419-93-0(Ginsenoside Rg6)
- 139975-46-5(b-D-Galactopyranoside, (1b,3b,16b,22S)-1-[(6-deoxy-a-L-mannopyranosyl)oxy]-3,22-dihydroxycholest-5-en-16-yl 3-O-(6-deoxy-a-L-mannopyranosyl)- (9CI))
- 100187-68-6(b-D-Glucopyranoside, (3b,6b)-5,6,16-trihydroxygrayanotox-9-en-3-yl (9CI))
- 142735-53-3(b-D-Galactopyranoside, (1b,3b,16b,22S)-1,3,22-trihydroxycholest-5-en-16-yl (9CI))
- 105558-26-7(Ginsenoside Rh3)
- 139953-18-7(b-D-Galactopyranoside, (3b,16b,22S)-3,22-dihydroxycholest-5-en-16-yl 3-O-(6-deoxy-a-L-mannopyranosyl)-)
- 139953-19-8(Cholest-5-ene-3,16,22-triol; (3β,16β,22S)-form, 3-O-β-D-Glucopyranoside, 16-O-[α-L-rhamnopyranosyl-(1→3)-β-D-galactopyranoside])
- 126223-28-7(Ginsenoside Rg4)
- 186763-78-0(Ginsenoside Rg5)